Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,650 total articles
EchoStar (SATS) looks vulnerable despite headline assets tied to SpaceX and a bitcoin treasury story. Credit friction at its pay-TV unit and the need to bankroll an aggressive bitcoin accumulation plan increase the chance of a drawn-out sell-off. I recommend a tactical short at $94.88 with a $80 target over the next 45 trading days and a protective…
Richardson Electronics (RELL) just cleared the checklist: improving top-line momentum, material backlog, new technology partnerships, and a pullback to below key moving averages that makes risk/reward favorable. I like a mid-term long trade with an entry at $17.66, a stop at $15.50, and a primary target at $23.00 (mid-term horizon: 45 trading days)…
Tower Semiconductor looks set to ride a multi-year growth cycle driven by silicon photonics scale-up, high-volume PIC shipments and strategic partnerships. Valuation is rich today, but recent operational wins, a capacity buildout and improving fundamentals create a defined, actionable long trade with a 180-trading-day horizon.
Ultra Clean (UCTT) supplies critical subsystems, parts and ultra-purity services to semiconductor manufacturers and wafer fab equipment (WFE) makers. With management expanding manufacturing capacity toward $4.0B annualized revenue capability by mid-2027 and consensus quarterly revenue near $725.5M, UCTT is structurally positioned to grow faster tha…
Sturm, Ruger & Co. (RGR) announced a strategic alliance with Beretta that strengthens its product pipeline and distribution optionality. With recent product-led sell-through growth, capacity investments in Kentucky, and healthy cash flow, RGR presents an asymmetric reward profile over the next 180 trading days if execution stays on plan. This trade…
Analog Devices pairs legacy analog strength with expanding AI and digital-platform businesses. The company offers a lower-debt balance sheet, healthy free cash flow and visible earnings upgrades, justifying a measured long with a clear entry, stop and target.
RingCentral’s Q3 beat, accelerating AI ARR ($400M ARR) and rising free cash flow make the company look inexpensive relative to its growth and profitability. This trade targets a disciplined long entry on the recent pullback with a clear stop and a long-term (180 trading days) target that assumes modest multiple expansion as AI monetization scales.
Planet Labs sells daily satellite imagery and analytics. With Q2 revenue momentum, an $815M backlog and accelerating Defense & Intelligence sales, the business has real demand — but the stock trades well below its 52-week high amid execution concerns and heavy reinvestment. This trade treats the pullback as a speculative buy: favorable backlog visi…
Agnico Eagle (AEM) remains a high-quality gold producer with diversified assets and steady cash generation. At roughly $88.6B market cap and a P/E near 15, the stock is trading at a premium to peers while recent technicals and estimate revisions suggest the market has priced much of the good news. We outline a mid-term (45 trading days) short trade…
Amkor (AMKR) trades at a meaningful discount to semiconductor peers after a sharp re-rate from its June highs. Nvidia-linked advanced packaging demand and improving Computing revenues give Amkor a clear fundamental path to re-rating. With Q3 earnings due 10/26/2026 and technicals showing oversold momentum, this is a mid-term swing trade to capture …
Ionis (IONS) combines a deep antisense platform with recent positive late-stage readouts from partnered programs and an approved niche product. At a market cap near $7.13B and an enterprise value of about $8.11B, the shares still price in significant execution risk. For patient, long-term investors who can tolerate ongoing losses and dilution risk,…
Heineken remains a high-quality cash-flow generator supported by an aggressive buyback program and steady dividends. At $43.30 the stock looks like a 'light' buy for swing traders who want exposure to stable beverage cash flow and buyback-driven EPS support. Valuation (market cap ~$49B, P/E ~18.2) is reasonable, but elevated RSI and proximity to th…
Nano Labs (NA) trades at a sub-$40M market cap after a H1 2026 hit of RMB316.7M (US$46.5M) largely from crypto fair-value losses. The stock is oversold technically, float is tight (~8.5M shares) and short interest remains meaningful. This is a high-risk, tactical long: enter at $1.65, target $2.50, stop $1.35, horizon mid term (45 trading days).
Applied Materials (AMAT) is trading well below recent highs after a sharp run. The company's Semiconductor Systems segment is growing, margins expanded to 38%, and management guided to $7.9B for Q4. With a market cap near $299B, strong cash generation and healthy balance sheet metrics, this pullback is a tactical buying opportunity. Trade plan: ent…
Meta reported underlying profitability and free cash flow strength, but the stock is trading lower after headlines about a large legal charge and an aggressive capex plan. With a $1.63T market cap, $28.6B of trailing free cash flow and a P/E near 22, this is a risk/reward setup for a mid-term bounce. I propose a defined long trade with a $642.26 en…
SK hynix should benefit from stronger DRAM/NAND pricing driven by an AI server buildout led by Micron and hyperscalers, but the sector's capital intensity and inventory dynamics create a narrow window to lock in gains. This trade idea outlines a tactical long with specific entry, stop and target levels and a multi-horizon monitoring plan.
Klaviyo is the B2C marketing CRM that many fast-growing ecommerce brands prefer. With 110% net revenue retention, positive free cash flow of $253.1M, a $2.58B cash cushion and a $500M buyback in motion, KVYO looks positioned to convert product leadership into durable cash generation. We view today’s price as an attractive entry for a long-term trad…
Bloom Energy reported blowout revenue growth and raised 2026 guidance, yet the stock plunged on cash-flow noise. Fundamentals — $1.236B Q3 revenue (+138% YoY), raised guidance to $4.4-4.6B, and sizable cash reserves — argue the selloff is overdone. This is a mid-term trade idea to buy the dip with a tight stop and a conservative target that capture…
<p>Mako Mining is trading roughly 48% below an implied net asset value (NAV), while the company is positioned to grow production over the next 12-18 months. For traders willing to take on mining project and execution risk, the risk/reward looks favorable: we lay out an entry at $0.60, a conservative target at $1.10 and a stop at $0.42. The trade is…
Kingstone (KINS) is a compact, well-capitalized regional P&C holding company. Management's move to reduce reinsurance layers should raise net underwriting margins and drive near-term earnings leverage. With a market cap of roughly $290M, a P/E near 8.2 and free cash flow of ~$83M, the stock offers an asymmetric risk-reward for a disciplined swing t…
Peabody (BTU) looks attractively priced relative to tangible assets and cash-flow upside if coal markets remain firm. Low leverage, a sub-$3 billion market cap and a ~0.7x price/sales multiple leave room for re-rating. This trade idea lays out an actionable long with entry, stop and target levels and the specific time horizon tied to likely catalys…
Ocular Therapeutix beat expectations on the clinical front with Phase 3 SOL-1 success for AXPAXLI, yet the stock has been punished by weak near-term revenue and aggressive shorting. With a market cap of $1.43B, $666.7M in cash and an enterprise value of $901.7M (net EV roughly $235M), the balance sheet gives management time to commercialize or fiel…
Vicor's Q3 beat and a $406M backlog show the company is converting AI infrastructure demand into revenue and cash. Valuation is rich, but momentum and margin expansion justify a mid-term long trade with a clear stop and a two-stage target plan.
Avalo Therapeutics ($AVTX) looks beaten down: the stock trades near its 52-week low while the company sits on meaningful financing sized to complete late-stage development of lead anti-IL-1β antibody abdakibart. For risk-tolerant traders willing to accept biotech binary risk, this is a tactical long opportunity ahead of Phase 3 catalysts, with a cl…
Phoenix Metals presents a classic microcap metals optionality trade: limited public attention, high operational and execution risk, but meaningful upside if near-term exploration results, permitting progress, or commodity repricing aligns. This idea is directional and speculative — trade with strict position sizing and a hard stop.
